Total Payments
$9,728
2024 Payments
$698.83
Companies
22
Transactions
362
Medicare Patients
2,320
Medicare Billing
$617,070
Payment Breakdown by Category
Food & Beverage$6,049 (62.2%)
Other$3,500 (36.0%)
Education$179.21 (1.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,049 | 354 | 62.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $3,500 | 2 | 36.0% |
| Education | $179.21 | 6 | 1.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $4,919 | 96 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $765.39 | 45 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $637.98 | 34 | $0 (2024) |
| Alkermes, Inc. | $626.12 | 33 | $0 (2024) |
| Allergan, Inc. | $515.93 | 36 | $0 (2020) |
| ITI, Inc. | $381.31 | 19 | $0 (2023) |
| Lundbeck LLC | $338.38 | 15 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $299.95 | 21 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $222.60 | 11 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $199.49 | 10 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $698.83 | 33 | ABBVIE INC. ($180.97) |
| 2023 | $4,770 | 71 | ABBVIE INC. ($3,922) |
| 2022 | $1,083 | 59 | Alkermes, Inc. ($241.71) |
| 2021 | $1,858 | 112 | AbbVie Inc. ($581.63) |
| 2020 | $760.53 | 47 | Allergan, Inc. ($376.61) |
| 2019 | $383.60 | 28 | Allergan Inc. ($139.32) |
| 2018 | $64.49 | 3 | Otsuka America Pharmaceutical, Inc. ($35.96) |
| 2017 | $109.10 | 9 | Otsuka America Pharmaceutical, Inc. ($109.10) |
All Payment Transactions
362 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/06/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $26.27 | General |
| Category: CNS | ||||||
| 12/05/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $21.83 | General |
| Category: PSYCHIATRY | ||||||
| 11/26/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $10.74 | General |
| Category: PSYCHIATRY | ||||||
| 11/26/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $1.07 | General |
| Category: PSYCHIATRY | ||||||
| 11/20/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.03 | General |
| Category: NEUROSCIENCE | ||||||
| 11/07/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.33 | General |
| Category: NEUROSCIENCE | ||||||
| 06/28/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $33.78 | General |
| Category: NEUROSCIENCE | ||||||
| 06/24/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $19.85 | General |
| Category: CNS | ||||||
| 06/18/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: CNS | ||||||
| 06/17/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $26.62 | General |
| Category: Neuroscience | ||||||
| 05/09/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Education | In-kind items and services | $12.15 | General |
| Category: PSYCHIATRY | ||||||
| 04/25/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $29.06 | General |
| Category: PSYCHIATRY | ||||||
| 04/16/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: CNS | ||||||
| 04/14/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $25.07 | General |
| Category: PSYCHIATRY | ||||||
| 04/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $26.16 | General |
| Category: NEUROSCIENCE | ||||||
| 04/08/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $18.94 | General |
| Category: Neuroscience | ||||||
| 03/26/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $7.69 | General |
| Category: CNS | ||||||
| 03/19/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $24.40 | General |
| Category: PSYCHIATRY | ||||||
| 03/07/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $20.26 | General |
| Category: Central Nervous System | ||||||
| 03/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $27.73 | General |
| Category: NEUROSCIENCE | ||||||
| 02/26/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $13.54 | General |
| Category: PSYCHIATRY | ||||||
| 02/22/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $23.74 | General |
| Category: PSYCHIATRY | ||||||
| 02/16/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $16.52 | General |
| Category: PSYCHIATRY | ||||||
| 02/14/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $21.39 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 02/13/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $27.91 | General |
| Category: Neuropsychiatry | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 551 | 2,140 | $348,470 | $161,704 |
| 2022 | 6 | 569 | 1,995 | $324,880 | $154,064 |
| 2021 | 7 | 591 | 1,788 | $295,395 | $144,221 |
| 2020 | 7 | 609 | 1,841 | $314,565 | $157,081 |
Total Patients
2,320
Total Services
7,764
Medicare Billing
$617,070
Procedure Codes
26
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 177 | 900 | $171,000 | $89,330 | 52.2% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 180 | 959 | $134,260 | $51,947 | 38.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 79 | 116 | $18,560 | $8,174 | 44.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 46 | 46 | $12,650 | $7,673 | 60.7% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2023 | 44 | 55 | $8,800 | $3,819 | 43.4% |
| 90785 | Psychiatric services complicated by communication factor | Office | 2023 | 25 | 64 | $3,200 | $761.60 | 23.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 169 | 826 | $156,940 | $83,039 | 52.9% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 169 | 817 | $114,380 | $45,918 | 40.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 53 | 53 | $14,490 | $9,217 | 63.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 77 | 114 | $18,270 | $7,792 | 42.6% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2022 | 73 | 105 | $16,800 | $7,151 | 42.6% |
| 90785 | Psychiatric services complicated by communication factor | Office | 2022 | 28 | 80 | $4,000 | $946.94 | 23.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 160 | 676 | $128,440 | $70,803 | 55.1% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Office | 2021 | 159 | 690 | $95,810 | $38,899 | 40.6% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 63 | 63 | $17,325 | $9,713 | 56.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 77 | 130 | $19,600 | $8,772 | 44.8% |
| 90837 | Psychotherapy, 60 minutes | Office | 2021 | 40 | 71 | $13,650 | $7,977 | 58.4% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2021 | 73 | 115 | $18,070 | $7,555 | 41.8% |
| 90785 | Interactive complexity | Office | 2021 | 19 | 43 | $2,500 | $502.25 | 20.1% |
| 90837 | Psychotherapy, 60 minutes | Office | 2020 | 96 | 445 | $88,150 | $50,103 | 56.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 130 | 494 | $93,860 | $42,921 | 45.7% |
| 90833 | Psychotherapy, 30 minutes | Office | 2020 | 132 | 500 | $65,000 | $29,093 | 44.8% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 79 | 79 | $21,725 | $12,219 | 56.2% |
| 90836 | Psychotherapy, 45 minutes | Office | 2020 | 75 | 146 | $21,860 | $10,950 | 50.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 76 | 156 | $20,220 | $9,693 | 47.9% |
About Michelle Kaplan
Michelle Kaplan is a Neurology healthcare provider based in Boca Raton, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/19/2007. The National Provider Identifier (NPI) number assigned to this provider is 1336263169.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Michelle Kaplan has received a total of $9,728 in payments from pharmaceutical and medical device companies, with $698.83 received in 2024. These payments were reported across 362 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($6,049).
As a Medicare-enrolled provider, Kaplan has provided services to 2,320 Medicare beneficiaries, totaling 7,764 services with total Medicare billing of $617,070. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Other Specialties Psychiatry
- Location Boca Raton, FL
- Active Since 03/19/2007
- Last Updated 11/07/2025
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1336263169
Products in Payments
- VRAYLAR (Drug) $5,435
- REXULTI (Drug) $869.67
- CAPLYTA (Drug) $516.13
- AUSTEDO (Drug) $484.94
- LYBALVI (Drug) $448.36
- SPRAVATO (Drug) $222.60
- LATUDA (Drug) $199.49
- TRINTELLIX (Drug) $195.47
- ARISTADA (Drug) $155.93
- ABILIFY MAINTENA (Drug) $143.09
- VYVANSE (Drug) $124.70
- NUEDEXTA (Drug) $123.52
- CITALOPRAM (Drug) $90.64
- QELBREE (Drug) $69.00
- ABILIFY MYCITE (Drug) $67.06
- LOREEV XR (Drug) $57.93
- INGREZZA (Drug) $54.45
- Azstarys (Drug) $48.73
- JORNAY PM (Drug) $43.80
- Austedo XR (Drug) $41.59
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Boca Raton
Dr. Stuart Isaacson, Md, MD
Neurology — Payments: $4.9M
Neurology $4.9M
Brian Steingo, Md, MD
Neurology — Payments: $1.4M
Neurology $1.4M
Dr. Brian Costell, M.d, M.D
Neurology — Payments: $638,608
Neurology $638,608
Dr. Patricio Espinosa, Md,Mph, MD,MPH
Neurology — Payments: $215,050
Neurology $215,050
Dr. Richard Isaacson, M.d, M.D
Neurology — Payments: $140,056
Neurology $140,056
Gediminas Gliebus, M.d, M.D
Neurology — Payments: $120,507
Neurology $120,507